Skip to main content
. 2020 Nov 23;7:69. doi: 10.1186/s40658-020-00338-3

Fig. 3.

Fig. 3

Percentage deviations of all the activity measurements used for analysis, for each system tested, for the therapeutic radionuclides. a 131I, b 177Lu, c 90Y (data not shown: D1 syringe 1 mL 158.2%, D1 syringe 3 mL 94.0%, H2 syringe 1 mL 423.9%, H2 syringe 3 mL 383.6%). Systems using sample geometry calibration/correction factors are labeled with an asterisk (*)